Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-19T18:14:24.216Z Has data issue: false hasContentIssue false

Postexposure Immunization and Prophylaxis of Bloodborne Pathogens Following a Traumatic Explosive Event: Preliminary Recommendations

Published online by Cambridge University Press:  08 April 2013

Abstract

Background: No definitive guidelines have been established in the United States for postexposure immunization and prophylaxis (PEP) to hepatitis B and C viruses (HBV, HCV) and human immunodeficiency virus (HIV) in the event of a traumatic explosive event.

Methods: The American Medical Association’s Center for Public Health Preparedness and Disaster Response assembled a US-Israeli panel of experts, including representatives from disaster medicine, trauma surgery, occupational health, and infectious disease to determine guidelines for adult and pediatric victims following a traumatic explosive event. The panel reviewed the existing Israeli and United Kingdom protocols, previously published Centers for Disease Control and Prevention guidance on occupational and nonoccupational exposures to HBV, HCV, and HIV, before reaching consensus on preliminary guidelines for the United States.

Results: These guidelines recommend an age-appropriate dose and schedule for HBV PEP for individuals presenting from the scene with nonintact skin or mucous membrane exposure, and they also consider HCV and HIV testing in individuals presenting with possible nonintact skin or mucous membrane exposure. The guidelines do not recommend PEP for individuals presenting from the scene with possible superficial skin exposure.

Conclusions: These recommendations offer PEP guidance for bloodborne pathogens and are limited in scope. These recommendations do not address general wound PEP such as tetanus or the need for antibiotics. It is hoped that these guidelines will fill an urgent gap in preparedness until definitive, comprehensive guidelines from the Centers for Disease Control and Prevention are published. (Disaster Med Public Health Preparedness. 2007;1:106–109)

Type
Original Research and Critical Analysis
Copyright
Copyright © Society for Disaster Medicine and Public Health, Inc. 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.DePalma, RG, Burris, DG, Champion, HR, Hodgson, MJ.Blast injuries. N Engl J Med. 2005;352:13351342.Google Scholar
2.Braverman, I, Wexler, D, Oren, M.A novel mode of infection with hepatitis B: penetrating bone fragments due to the explosion of a suicide bomber. Isr Med Assoc J. 2002;4:528529.Google Scholar
3.Eshkol, Z, Katz, K.Injuries from biologic materials of suicide bombers. Injury. 2005;36:271274.CrossRefGoogle ScholarPubMed
4.Leibner, ED, Weil, Y, Gross, E, Liebergall, M, Mosheiff, R.A broken bone without a fracture: traumatic foreign bone implantation resulting from a mass casualty bombing. J Trauma. 2005;58:388390.CrossRefGoogle ScholarPubMed
5.Wong, JM, Marsh, D, Abu-Sitta, G, et alBiological foreign body implantation in victims of the London July 7th suicide bombings. J Trauma. 2006;60:402404.Google Scholar
6. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposure to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR http://www.cdc.gov/mmwr/PDF/RR/RR5011.pdf. Published June 29, 2001. Accessed June 8, 2007.Google Scholar
7. Post-exposure prophylaxis against hepatitis B for bomb victims and immediate care providers. Consideration of other blood borne viruses (hepatitis C and HIV). Health Protection Agency Web site. http://www.hpa.org.uk/explosions/BBV.htm. Accessed June 7, 2007.Google Scholar
8.Frykberg, ER, Tepas, JJ.Terrorist Bombings. Lessons Learned From Belfast to Beirut. Ann Surg. 1998: 569576.Google Scholar
9.Frykberg, ER.Medical management of disasters of mass casualties from terrorist bombings: how can we cope? J Trauma. 2002;53:201202.Google Scholar
10.Hogan, DE, Waeckerle, JF, Dire, DJ, Lillibridge, SR.Emergency department impact of the Oklahoma City terrorist bombing. Ann Emerg Med. 1999;34:160167.CrossRefGoogle ScholarPubMed
11.Mallonee, S, Shariat, S, Stennies, G, Waxweiler, R, Hogan, D, Jordan, F.Physical injuries and fatalities resulting from the Oklahoma City bombing. JAMA. 1996;276:382387.Google Scholar
12.Glenshaw, MT, Vernick, JS, Li, G, Sorock, GS, Brown, S, Mallonee, S.Preventing fatalities in building bombings: what can we learn from the Oklahoma City bombing? Disaster Med Public Health Preparedness. 2007: 2731.Google Scholar
13.Peral-Gutierrez de Ceballos, J, Turégano-Fuentes, F, Pérez-Diaz, D, et alCasualties treated at the closest hospital in the Madrid, March 11, terrorist bombings. Crit Care. 2005;9:104111.Google Scholar
14.Aylwin, CJ, König, TC, Brennan, NW, et alReduction in critical mortality in urban casualty incidents: analysis of triage, surge, and resource use after the London bombings on July 7, 2005. Lancet. 2006;368:22192225.Google Scholar
15.Peleg, K, Aharonson-Daniel, L, Stein, M, et alGunshot and explosion injuries: characteristics, outcomes, and implications for care of terror-related injuries in Israel. Ann Surg. 2004;239:311317.Google Scholar
16.Almogy, G, Belzberg, H, Mintz, Y, Pikarsky, AK, Zamir, G, Rivkind, AI.Suicide bombing attacks: update and modifications to the protocol. Ann Surg. 2004;239:295303.Google Scholar
17.Einav, S, Feigenberg, Z, Weissman, C, et alEvacuation priorities in mass casualty terror-related events: implications for contingency planning. Ann Surg. 2004;239:304310.Google Scholar
18.Siegel-Itzkovich, J.Israeli minister orders hepatitis B vaccine for survivors of suicide bomber attacks. Br Med J. 2001;323:417.Google Scholar
19. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: immunization of adults. MMWR. 2006;55(No. RR-16):1–25.Google Scholar
20. Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-related Chronic Disease MMWR. 1998;47(No. RR-19).Google Scholar
21.Armstrong, GL, Wasley, A, Simard, EP, et alThe prevalence of hepatitis C virus infection in the United States, 1999-2002. Ann Intern Med. 2006;14:705714.CrossRefGoogle Scholar
22. HIV/AIDS Surveillance Report, Vol 17. Cases of HIV Infection and AIDS in the United States and Dependent Areas, 2005. Revised June 2007. http://www.cdc.gov/HIV/topics/surveillance/resources/reports/2005report/default.htm. Accessed September 10, 2007.Google Scholar
23. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR. 2005;54(No. RR-9): 1–17.Google Scholar
24.Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. MMWR. 2005;54 (RR02):120.Google Scholar
25.National, state, and urban vaccination coverage among children aged 19–35 months—United States, 2005. MMWR. 2006;55:988993.Google Scholar
26. Stokley et al Adolescent vaccine coverage levels: results from the 1997–2003 National Health Interview Survey. Paper presented at the 40th National Immunization Conference, Atlanta, GA; March 6, 2006.Google Scholar
27.Hepatitis B vaccination among adults—United States, 2004. MMWR. 2006;55:509511.Google Scholar
28. Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health Care Settings. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm. Accessed June 8, 2007.Google Scholar
29. Immunization Schedules. http://www.cdc.gov/vaccines/recs/schedules/default.htm. Accessed September 10, 2007.Google Scholar